Opinion

Video

Advice for Clinicians Treating IPF

Author(s):

Steven D. Nathan, MD

Dr Nathan provides his final thoughts regarding IPF management.

Video content above is prompted by the following:

  • Please describe the importance of early diagnosis in idiopathic pulmonary fibrosis (IPF) treatment.
  • What should clinicians in the community know about treating IPF?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
1 expert in this video
Ayodeji Adegunsoye, MD, PhD, MSc
4 experts in this video
4 experts in this video
Marilyn Glassberg, MD
Dr Caroline Vovan
Related Content
Woman and child holding red ribbon | Image credit: ArvStd - stock.adobe.com
July 24th 2025

High Burdens of Drug Resistance Found in Children With HIV

Julia Bonavitacola
Mother-to-child transmission often led to pretreatment drug resistance and acquired drug resistance in children living with HIV.
managed care cast logo
July 24th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM
This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.
The findings showed that certain IPF phenotypes had a significant association with hypothyroidism. | Image credit: surasak - stock.adobe.com
July 23rd 2025

Immune Cell Phenotypes Linked With Hypothyroidism, IPF

Jared Kaltwasser
Thirty-six immune cell phenotypes were flagged as having an association with idiopathic pulmonary fibrosis (IPF).
managed care cast logo
December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick
On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
Adcetris packaging | Image: Pfizer
July 23rd 2025

Real-World Study Finds Brentuximab Vedotin With Chemo Is Safe, Effective in First-line Treatment of PTCL

Mary Caffrey
Brentuximab vedotin combined with cyclophosphamide, doxorubicin, and prednisone (CHP) shows promising results as a first-line treatment in newly diagnosed peripheral T-cell lymphoma (PTCL).
G
July 23rd 2025

In Data Race, Flatiron Health Touts Tripling of Global Oncology Research Network

Mary Caffrey
Flatiron Health expands its international oncology research network, enhancing real-world data use to improve patient outcomes and cancer care globally.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo